Company
Lutonix
- Business model
- B2B
Record updated 28 September 2026
About
is focused on the development of a drug-coated balloon angioplasty catheter intended to reduce restenosis. Targeted clinical indications include lower extremity peripheral vascular disease and coronary in-stent restenosis. The company was founded in 2007 by engineer Lixiao Wang and interventional cardiologist and entrepreneur Dennis Wahr.